IVIG for refractory dysphagia in Antisynthetase syndrome: A truth hard to swallow

Authors

Mais Alnoukari, The University of Texas Rio Grande Valley
Oziel Garza De La Garza, The University of Texas Rio Grande Valley
Karrar Al Gburi, The University of Texas Rio Grande Valley
Niral Patel, The University of Texas Rio Grande Valley
Henderson Lopez, The University of Texas Rio Grande Valley
Muhammad Shamim, The University of Texas Rio Grande Valley
Henry Kwang, The University of Texas Rio Grande ValleyFollow

Document Type

Article

Publication Date

11-13-2022

Abstract

Refractory dysphasia could be the main symptom of Antisynthetase syndrome (ASS). IVIG may have a major impact in the successful treatment of dysphasia in patients with ASS. In our patient with ASS, IVIG treatment was an unreplaceable treatment option, and the patient regains her ability to swallow within 2 days.

Comments

© 2022 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.

Recommended Citation

Alnoukari, M, De La Garza, OG, Al Gburi, K, et al. IVIG for refractory dysphagia in Antisynthetase syndrome: A truth hard to swallow. Clin Case Rep. 2022; 10:e06569. doi: 10.1002/ccr3.6569

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-No Derivative Works 4.0 International License.

Publication Title

Clinical Case Reports

DOI

10.1002/ccr3.6569

Academic Level

faculty